- Home
- A-Z Publications
- Current Pharmaceutical Analysis
- Previous Issues
- Volume 18, Issue 9, 2022
Current Pharmaceutical Analysis - Volume 18, Issue 9, 2022
Volume 18, Issue 9, 2022
-
-
A Review: Recent Analytical Applications on Anti-epileptic Agents
Authors: Reshma N. Shelke, Ramanlal N. Kachave and Manoj V. MahaleEpilepsy is one of the chronic diseases seen in 1.0% of the world’s population. For the study of antiepileptic medications, a variety of approaches have been used extensively. These methods provide reliable, accurate, and reproducible results. The available analytical methods for the determination of AEDs in API, biological fluids, and pharmaceutical formulations are reviewed in this context. The drugs categorized und Read More
-
-
-
UPLC-MS-based Method Development, Validation, and Optimization of Dissolution Using Quality by Design Approach for Low Dose Digoxin: A Novel Strategy
Authors: Hemanth V. P.R., Narasimha M. Beeraka, Pramod Kumar, Hitesh B. Patel and B.M. GurupadayyaBackground: Digoxin, a cardiac glycoside, is one of the most significant drugs of choice for treating congestive heart failure. As digoxin is a BCS class IV drug, dissolution is a critical quality attribute during its solid dosage formulation. Methods: This study aims to quantify the drug release during dissolution for low dosage digoxin of 0.0625 mg tablets with a targeted drug release of more than 80% at 60 minutes. We used a Read More
-
-
-
GC-FID Quantification of N, N-Dimethyl Aminopropyl Chloride, a Genotoxic Impurity, in Imipramine Hydrochloride and Clomipramine Hydrochloride
Authors: Panga Chinna, Shet Prakash M., Ramesha A. Ramakrishna, Swamy Sreenivasa and Yashbir SinghBackground: Early antidepressant Active Pharmaceutical Ingredients (API), like imipramine hydrochloride and clomipramine hydrochloride, have not been assessed for Genotoxic Impurities (GTI) as per ICHM7. Objective: The main aim of the study was to develop a new simple and sensitive method for the determination of genotoxic impurities in imipramine hydrochloride and clomipramine hydrochloride active pharmaceutic Read More
-
-
-
Charge Variants Analysis of a Bispecific Antibody Using a Fully Automated One-step Capillary Isoelectric Focusing - Mass Spectrometry Method
Authors: Gang Wu, Chuanfei Yu, Wenbo Wang, Jialiang Du, Gangling Xu, Zhihao Fu and Lan WangBackground: Bispecific antibody (BsAb) therapeutics have emerged as the nextgeneration immuno-oncology therapy. The architecture of bsabs is inherently more complex than that of mAb therapeutics. As a result, prior knowledge of critical quality attributes (CQAs) assessment of mAbs is no longer inclusive for bsabs. Objective: The main objective of this work is to develop a fully automated one-step capillary isoelectric focusi Read More
-
-
-
Development and Validation of A High-Performance Liquid Chromatography- Mass Spectroscopy Assay for the Bioequivalence Study of Guanfacine Extended Release (GXR) Tablet in Human Plasma
Authors: Jinying Wang and Qiaogen ZouGuanfacine, an α2-adrenergic (α2A) agonist long indicated to treat hypertension, is now being used to treat attention deficit hyperactivity disorder (ADHD) in adolescents. A simple, rapid high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS) method to detect and quantify guanfacine provides a basis for studying its bioequivalence and pharmacokinetics in human plasma. This assay involves quantitation of g Read More
-
-
-
Comprehensive Metabolomic Analysis of Lung Cancer Patients Treated with Fu Zheng Fang
Authors: Juan Lv, Yujiao Hua and Yongjuan DingBackground: Lung cancer remains one of the leading cancers with increasing mortality rates in the world. The clinicians in our hospital summarized “Fu Zheng Fang (FZF)” as a Chinese medicine prescription with good therapeutic effect and low adverse reactions to treat lung cancer. Objective: This research aimed to conduct an in-depth study on the essence and internal rules of the effect of FZF. Methods: Serum samples from t Read More
-
-
-
iTRAQ-based Proteomics Analysis of ADTM for Preventing the Development of Nitroglycerin-induced Tolerance
Authors: Huihui Hu, Jia Wu, Baojian Guo, Yuqiang Wang and Luchen ShanBackground: Long-term nitroglycerin (NTG) therapy causes tolerance, which limits its clinical application. Previous studies have reported a novel Danshensu/tetramethylpyrazine derivative ADTM, which displays strong cardioprotective effects. However, the effect of ADTM is not known in the NTGinduced tolerance model. In this study, we aimed to evaluate the potential improvement and underlying mechanism of ADTM for pr Read More
-
-
-
Evaluation and Application of ZIC-HILIC Columns Selectivity for Four Angiotensin II Receptor Blockers in Pharmaceutical Formulations
Authors: Ayad K. Fadhil, Ashraf S. Rasheed and Mohammed Jasim M. HassanBackground: Angiotensin II receptor blockers (ARBs) are helpful medications for treating hypertension and heart failure and have been proposed as a possible alternative to standard angiotensin-converting enzyme inhibitors. Objective: The present article describes and validates sensitive hydrophilic interaction liquid chromatography methods to simultaneously analyse four angiotensin II receptor blockers: valsartan, telmis Read More
-
Volumes & issues
-
Volume 20 (2024)
-
Volume 19 (2023)
-
Volume 18 (2022)
-
Volume 17 (2021)
-
Volume 16 (2020)
-
Volume 15 (2019)
-
Volume 14 (2018)
-
Volume 13 (2017)
-
Volume 12 (2016)
-
Volume 11 (2015)
-
Volume 10 (2014)
-
Volume 9 (2013)
-
Volume 8 (2012)
-
Volume 7 (2011)
-
Volume 6 (2010)
-
Volume 5 (2009)
-
Volume 4 (2008)
-
Volume 3 (2007)
-
Volume 2 (2006)
-
Volume 1 (2005)
Most Read This Month
Article
content/journals/cpa
Journal
10
5
false
en
